Clinical Protocol to Prevent Thrombogenic Effect of Liver-Derived Mesenchymal Cells for Cell-Based Therapies

The efficacy of mesenchymal stem cell infusion is currently tested in numerous clinical trials. However, therapy-induced thrombotic consequences have been reported in several patients. The aim of this study was to optimize protocols for heterologous human adult liver-derived progenitor cell (HHALPC)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cells
Autors principals: Coppin, Louise, Najimi, Mustapha, Bodart, Julie, Rouchon, Marie-Sophie, van der Smissen, Patrick, Eeckhoudt, Stéphane, Dahlqvist, Géraldine, Castanares-Zapatero, Diego, Komuta, Mina, Brouns, Sanne L., Baaten, Constance C., Heemskerk, Johan W. M., Horman, Sandrine, Belmonte, Nathalie, Sokal, Etienne, Stéphenne, Xavier
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721739/
https://ncbi.nlm.nih.gov/pubmed/31394759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8080846
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars